<ul><li>Navina, a provider of AI-powered clinical intelligence, has raised $55 million in a Series C funding round, bringing its total funding to $100 million.</li><li>The investment, led by Growth Equity at Goldman Sachs Alternatives, will fuel Navina's expansion across the U.S. healthcare market and drive further innovation in its AI technology.</li><li>Navina's AI copilot equips clinicians and care teams with real-time, data-driven insights, improving care quality, and financial outcomes. Its seamless integration into clinician workflows and high usage rate demonstrate the trust placed in its AI recommendations.</li><li>The funding will enhance Navina's AI copilot and support its expansion into broader healthcare segments, with over 10,000 healthcare professionals across 1,300 clinics already using the platform.</li></ul>

Navina Secures $55M to Expand AI-Powered Clinical Intelligence

Discover more